CDK2 and melanoma: Zhao et al. [15] showed that another Mcl-1 inhibitor-demethylzeylasteral inhibited Mcl-1 protein and accelerated the ubiquitin-dependent degradation of CDK2 in melanoma cells which resulted in cell cycle arrest at S phase.